Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank.
Domingues TD, et al. (2021) Herpesviruses Serology Distinguishes Different Subgroups […]
Research Papers
The UK ME/CFS Biobank for biomedical research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis.
Lacerda EM, et al. (2017) The UK ME/CFS Biobank for
The UK ME/CFS Biobank: a disease-specific biobank for advancing clinical research into myalgic encephalomyelitis/chronic fatigue syndrome,
Lacerda EM, et al. (2018) The UK ME/CFS Biobank: a
Complement Component C1q as a Potential Diagnostic Tool for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Subtyping.
Castro-Marrero J, et al . (2021) Complement Component C1q as
Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome With Partial Least Squares Discriminant Analysis: Relevance of Blood Extracellular Vesicles.
González-Cebrián A, et al. Frontiers in Medicine 9:842991.
Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome.
Gravelsina S, et al. (2022) Biomarkers in the diagnostic algorithm
No difference in serum levels of B-cell activating receptor and antibodies against cytolethal distending toxin B and flagellin in post-infectious irritable bowel syndrome and chronic fatigue syndrome after
Hanevik K, et al. (2022) No difference in serum levels
Saliva fatigue biomarker index as a marker for severe myalgic encephalomyelitis/chronic fatigue syndrome in a community based sample.
Jason LA, et al. (2021) Saliva fatigue biomarker index as
A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity.
Kedor C, et al . (2022) A prospective observational study
mapMECFS: a portal to enhance data discovery across biological disciplines and collaborative sites.
Mathur R, et al. (2021) mapMECFS: a portal to enhance
Induced pluripotent stem cells as suitable sensors for fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome.
Monzón-Nomdedeu MB, et al World Journal of Stem Cells 13
The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?
Murga I, et al. (2021) The maintained attention assessment in
The occurrence of hyperactivated platelets and fibrinaloid microclots in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Nunes M, et al. (2022) The occurrence of hyperactivated platelets
Cytokine Hub Classification of PASC, ME-CFS and other PASC-like Conditions.
Cytokine Hub Classification of PASC, ME-CFS and other PASC-like Conditions. Read More »
Patterson BK, et al. (2022) Cytokine Hub Classification of PASC,
The use of oxygen as a possible screening biomarker for the diagnosis of chronic fatigue.
Pifarr� F, et al. (2022) The use of oxygen as
Submaximal Exercise Provokes Increased Activation of the Anterior Default Mode Network During the Resting State as a Biomarker of Postexertional Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Rayhan RU and Baraniuk JN (2021) Submaximal Exercise Provokes Increased
Chronic fatigue syndrome and epigenetics: The case for hyperbaric oxygen therapy in biomarker identification.
Shah RJ. (2021) Chronic fatigue syndrome and epigenetics: The case
Revisiting IgG antibody reactivity to Epstein-Barr virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and its potential application to disease diagnosis.
Sep�lveda N, et al. (2022) Revisiting IgG antibody reactivity to
Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology.
Estevez-Lopez F, et al. (2020) Systematic Review of the Epidemiological